Invention Grant
- Patent Title: Monoclonal antibodies and cocktails for treatment of Ebola infections
-
Application No.: US16897027Application Date: 2020-06-09
-
Publication No.: US11407817B2Publication Date: 2022-08-09
- Inventor: Zachary A. Bornholdt , Larry Zeitlin , Kartik Chandran , Anna Z. Wec , Laura Walker
- Applicant: MAPP BIOPHARMACEUTICAL, INC. , Albert Einstein College of Medicine , Adimab, LLC
- Applicant Address: US CA San Diego; US NY Bronx; US NH Lebanon
- Assignee: MAPP BIOPHARMACEUTICAL, INC.,Albert Einstein College of Medicine,Adimab, LLC
- Current Assignee: MAPP BIOPHARMACEUTICAL, INC.,Albert Einstein College of Medicine,Adimab, LLC
- Current Assignee Address: US CA San Diego; US NY Bronx; US NH Lebanon
- Agency: Kilpatrick Townsend & Stockton LLP
- Main IPC: C07K16/10
- IPC: C07K16/10 ; A61P31/14 ; A61K39/42 ; A61K39/00
Abstract:
Described herein are compositions and methods for the prevention and treatment of ebolavirus infection. In certain embodiments of the present invention, monoclonal antibodies substantially similar to those described herein, as well as affinity matured variants thereof, alone or in combination, provide therapeutic efficacy in a patient against multiple species of ebolavirus.
Public/Granted literature
- US20200299363A1 MONOCLONAL ANTIBODIES AND COCKTAILS FOR TREATMENT OF EBOLA INFECTIONS Public/Granted day:2020-09-24
Information query
